Evidence map›Paper›PMID 41961781›Full record

ArticlePloS one2026

Sequencing complete plasmids on Oxford Nanopore Technologies sequencers using R2C2 and Chopper.

Kayla D Schimke, Christopher Vollmers

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kayla D SchimkeDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Christopher VollmersDepartment of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.ORCID https://orcid.org/0000-0002-7626-6222

Funding

Realizing the potential of long-read sequencing technologyR35GM133569 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Christopher Vollmers · 2019 to 2026
$3.4M
NIGMS NIH HHS R35 GM133569
6 · The paper itself

Abstract

Plasmids are ubiquitous tools in molecular biology which are used for a large variety of experiments within academic and commercial labs. Both new and old plasmids have to undergo sequencing-based analysis to determine whether or not they are functional, i.e., contain the correct insert in the correct backbone. While traditional Sanger sequencing based analysis was most often limited to the inserts, new high-throughput sequencing based methods and services can now provide the complete sequence of a plasmid. Currently available methods and services vary in throughput and cost. Here, we adapted the Oxford Nanopore Technologies-based R2C2 sequencing method to - rapidly and at low cost - sequence complete plasmids, either individually or in a pool. We also developed an analysis pipeline, Chopper, that produces full-length plasmid sequences. We tested our workflow with commonly used plasmids we ordered from Addgene and produced highly accurate sequences for each plasmid from both their individual and pooled sequencing runs.

Indexed as

High-Throughput Nucleotide SequencingNanopore SequencingPlasmidsSequence Analysis, DNANanopores

Identifiers

PMID41961781
PMCPMC13068223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.